Home › Funds › Marshall Wace › CLOV
Marshall Wace position in CLOV
CLOVER HEALTH INVESTMENTS CO · Health Care
Latest position (Q2 2026)1.56M sh
Reported value held$8.19M
Portfolio Weight0.01%
First reportedQ4 2021
Last changeNew
Quarter by quarter
| Quarter | Shares | Value | Change |
|---|---|---|---|
| Q4 2021 | 1.25M | $4.63M | New |
| Q2 2024 | 44.86K | $55.17K | New |
| Q3 2024 | 1.41M | $3.97M | Add |
| Q4 2024 | 3.77M | $11.87M | Add |
| Q1 2025 | 4.58M | $16.43M | Add |
| Q2 2025 | 3.52M | $9.83M | Reduce |
| Q2 2026 | 1.56M | $8.19M | New |
Dots on the line are colored by change type; missing quarters mean no position was reported.
Other funds holding CLOV
- BlackRock Inc 35.11M sh · $183.96M · Q2 2026
- Geode Capital Management 10.85M sh · $56.84M · Q2 2026
- Vanguard Group 23.49M sh · $55.19M · Q4 2025
- Charles Schwab Investment Management 5.52M sh · $28.93M · Q2 2026
- Citadel Advisors 4.38M sh · $22.94M · Q2 2026
- Northern Trust Corp 3.77M sh · $19.77M · Q2 2026
- PNC Financial Services 3.56M sh · $18.67M · Q2 2026
- Renaissance Technologies 2.81M sh · $14.71M · Q2 2026
- Morgan Stanley 2.29M sh · $12.02M · Q2 2026
- D. E. Shaw & Co 1.97M sh · $10.30M · Q2 2026
- Invesco Ltd 1.34M sh · $7.00M · Q2 2026